ArticleCureus2026
Clinical and Laboratory Factors Associated With In-Hospital Mortality Among Patients With Decompensated Liver Cirrhosis: A Retrospective Study From Indonesia.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLiver cirrhosis is a major cause of morbidity and mortality worldwide. Identification of clinical and laboratory factors associated with mortality may help clinicians identify high-risk hospitalized patients with decompensated liver cirrhosis.
methodsA retrospective cohort study was conducted among 190 patients with decompensated liver cirrhosis admitted to Adam Malik General Hospital, Medan, Indonesia, between January 2022 and December 2023. Demographic, clinical, and laboratory data were obtained from medical records. Bivariate analyses were performed using chi-square, Fisher's exact, and Mann-Whitney U tests as appropriate.
resultsAmong the 190 patients included in the study, 79 (41.6%) died during hospitalization. Bivariate analysis showed that grade III-IV hepatic encephalopathy, abnormal leukocyte count, low serum albumin levels, elevated total bilirubin, elevated serum creatinine, increased INR, hyponatremia, and higher albumin-bilirubin (ALBI) grade, Child-Pugh class, model for end-stage liver disease (MELD), and MELD sodium (MELD-Na) scores were significantly associated with in-hospital mortality (p < 0.05). In contrast, age, sex, comorbidities, and upper gastrointestinal bleeding at admission were not significantly associated with mortality.
conclusionIn-hospital mortality among decompensated cirrhotic patients remains high. Several clinical and laboratory parameters, including hepatic encephalopathy, leukocyte count, albumin, bilirubin, creatinine, INR, and sodium levels, were significantly associated with mortality. Early recognition of these factors may help clinicians identify high-risk patients with decompensated liver cirrhosis during hospitalization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.